Order Article Reprints

Roy S, Laroche-Clary A, Verbeke S, Derieppe M-A, Italiano A. MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies. Cancers. 2020; 12(8):2253. https://doi.org/10.3390/cancers12082253

Roy, Shomereeta, Audrey Laroche-Clary, Stephanie Verbeke, Marie-Alix Derieppe, and Antoine Italiano. 2020. "MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies" Cancers 12, no. 8: 2253. https://doi.org/10.3390/cancers12082253

Roy, S., Laroche-Clary, A., Verbeke, S., Derieppe, M. -A., & Italiano, A. (2020). MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies. Cancers, 12(8), 2253. https://doi.org/10.3390/cancers12082253